Dr. Farrugia publishes “Prognostic Significance of Modified Residual Disease in Breast and Nodes (mRDBN) Algorithm After Neoadjuvant Chemotherapy for Breast Cancer”

Prognostic Significance of Modified Residual Disease in Breast and Nodes (mRDBN) Algorithm After Neoadjuvant Chemotherapy for Breast Cancer.

Clark BZ, Farrugia DJ, Landmann A, Diego EJ, Dabbs DJ, Puhalla SL, Jankowitz RC, Brufsky AM, Ahrendt GM, McAuliffe PF, Bhargava R.

Am J Clin Pathol. 2018 Mar 7;149(4):332-343

 

Click the link below for full text of publication:

Daniel Farrugia MD PhD – Prognostic Significance of Modified Residual Disease in Breast Cancer

Daniel J Farrugia MD PhD Administrator
Director, Centegra Comprehensive Breast Program
Daniel Farrugia MD PhD is a fellowship-trained breast surgeon in the northern suburbs of Chicago. He is Director of the Centegra Comprehensive Breast Program. His research in breast cancer has been published in top international journals, and has been cited over a thousand times in the medical literature.
follow me

Leave a Reply

Your email address will not be published. Required fields are marked *